Humanities
Skip to main content Skip to main navigation menu Skip to site footer
  • Register
  • Login
  • Menu
  • Home
  • Current
  • Archives
  • Announcements
  • About
    • About the Journal
    • Submissions
    • Editorial Team
    • Privacy Statement
    • Contact
  • Register
  • Login

Journal of Education, Health and Sport

Review of Raynaud’s phenomenon: pathomechanisms, diagnosis and treatment
  • Home
  • /
  • Review of Raynaud’s phenomenon: pathomechanisms, diagnosis and treatment
  1. Home /
  2. Archives /
  3. Vol. 72 (2024) /
  4. Health Sciences

Review of Raynaud’s phenomenon: pathomechanisms, diagnosis and treatment

Authors

  • Aleksandra Marczyk St. John Paul II Municipal Hospital in Elblag, Poland https://orcid.org/0009-0006-4947-3900
  • Karolina Makowska Szpital Miejski św. Jana Pawła II w Elblągu; St. John Paul II Municipal Hospital in Elblag https://orcid.org/0009-0009-1997-1070
  • Marta Billewicz Powiatowe Centrum Zdrowia w Brzezinach; The District Health Center in Brzeziny https://orcid.org/0009-0009-4955-2213
  • Laura Lis Uniwersytet Medyczny w Łodzi; Medical University of Lodz https://orcid.org/0009-0008-2143-4306
  • Aleksandra Turek Powiatowe Centrum Medyczne w Grójcu; The District Medical Centre in Grójec https://orcid.org/0009-0003-5178-1978
  • Adam Popiołek Uniwersytet Medyczny w Łodzi; Medical University of Lodz https://orcid.org/0009-0004-7398-0801
  • Julia Pietrzykowska Uniwersytet Medyczny w Łodzi; Medical University of Lodz https://orcid.org/0009-0001-3000-7145
  • Oksana Zatorska Szpital Miejski św. Jana Pawła II w Elblągu; St. John Paul II Municipal Hospital in Elblag https://orcid.org/0009-0000-6273-6484

DOI:

https://doi.org/10.12775/JEHS.2024.72.51508

Keywords

Raynaud’s phenomenon, Raynauld’s disease, Raynauld’s syndrome, diagnosis, treatment

Abstract

Introduction: Raynaud’s phenomenon (RP) is a quite common but often unrecognised vasospastic condition of the peripheral vessels. This may happen after exposure to the cold, stress, vibrations or a wide range of medical conditions. It causes episodic colour changes of the digits, firstly there is a pallor, followed by cyanosis and/or redness, usually with pain. Raynaud’s phenomenon can be primary (i.e. Raynaud’s disease) or secondary (i.e. Raynaud’s syndrome) to underlying disease. 

Aim of the study: The aim of the study was to discuss the complex and incompletely understood pathophysiology of Raynaud’s phenomenon and to evaluate treatment approaches of both ‘uncomplicated’ - mostly primary and ‘complicated’ - mostly secondary Raynaud’s phenomenon.

State of knowledge: Raynaud’s phenomenon is a common disorder with an unclear pathophysiology. Although many treatment approaches have been  reported, there is still no cure or gold standard therapy. Further investigations into treatment are required. 

Conclusions: Future research is needed to understand the complex pathogenesis of RP and to develop optimised approaches to management. 

References

Choi E, Henkin S. Raynaud’s phenomenon and related vasospastic disorders. Vascular Medicine. 2021;(1):56-70. doi:10.1177/1358863x20983455

Temprano K. A Review of Raynaud’s Disease - PMC. PubMed Central (PMC). 2016;(113(2)):123-126. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6139949/ (Accessed May 14, 2024)

Herrick AL. Raynaud’s phenomenon. Journal of Scleroderma and Related Disorders. 2019;(2):89-101. doi:10.1177/2397198319826467

Gualtierotti R, Ingegnoli F, Griffini S, et al. Detection of early endothelial damage in patients with Raynaud’s phenomenon. Microvascular Research. Published online September 2017:22-28. doi:10.1016/j.mvr.2017.04.004 (Accessed May 14, 2024)

Herrick A, Muir L. Raynaud’s phenomenon (secondary) - PMC. PubMed Central (PMC). Published online October 2014. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4200538/ (Accessed May 14, 2024)

Pope JE. Raynaud’s phenomenon (primary) - PMC. PubMed Central (PMC). Published October 2013. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3794700/ (Accessed May 14, 2024)

Haque A, Hughes M. Raynaud’s phenomenon. Clinical Medicine. 2020;(6):580-587. doi:10.7861/clinmed.2020-0754

Zamora MR, O’Brien RF, Rutherford RB. Serum endothelin-1 concentrations and cold provocation in primary Raynaud’s phenomenon. The Lancet. 1990;(8724):1144-1147. doi:10.1016/0140-6736(90)92766-b

Fardoun MM, Nassif J, Issa K, Baydoun E, Eid AH. Raynaud’s Phenomenon: A Brief Review of the Underlying Mechanisms. Frontiers in Pharmacology. Published online November 16, 2016. doi:10.3389/fphar.2016.00438 (Accessed May 14, 2024)

Smyth AE. Digital vascular responses and serum endothelin-1 concentrations in primary and secondary Raynaud’s phenomenon. Annals of the Rheumatic Diseases. 2000;(11):870-874. doi:10.1136/ard.59.11.870

Żuk J, Snarska-Drygalska A, Malinowski K, Papuga-Szela E, Natorska J, Undas A. Unfavourably altered plasma clot properties in patients with primary Raynaud’s phenomenon: association with venous thromboembolism | Journal of Thrombosis and Thrombolysis. SpringerLink. Published online 2019:248-254. http://link.springer.com/article/10.1007/s11239-019-01805-0 (Accessed May 14, 2024)

Abdulle AE, Diercks GFH, Feelisch M, Mulder DJ, Goor H van. The Role of Oxidative Stress in the Development of Systemic Sclerosis Related Vasculopathy. Frontiers in Physiology. Published online August 24, 2018. doi:10.3389/fphys.2018.01177 (Accessed May 14, 2024)

Munir S, Freidin MB, Brain S, Williams FMK. Association of Raynaud’s phenomenon with a polymorphism in the NOS1 gene. Crispin JC, ed. PLOS ONE. 2018;(4):e0196279. doi:10.1371/journal.pone.0196279

Smith V, Herrick AL, Ingegnoli F, et al. Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud’s phenomenon and systemic sclerosis. Autoimmunity Reviews. 2020;(3):102458. doi:10.1016/j.autrev.2020.102458

Musa R, Qurie A. Raynaud Disease - StatPearls - NCBI Bookshelf. National Center for Biotechnology Information. https://www.ncbi.nlm.nih.gov/books/NBK499833// (Accessed May 14, 2024)

Haque A, Hughes M. Raynaud’s phenomenon. Clinical Medicine. 2020;(6):580-587. doi:10.7861/clinmed.2020-0754

Maricq HR, Carwile LeRoy E. Patterns of finger capillary abnormalities in connective tissue disease by “wide‐field” microscopy. Arthritis & Rheumatism. 1973;(5):619-628. doi:10.1002/art.1780160506

Haque A, Hughes M. Raynaud’s phenomenon. Clinical Medicine. 2020;(6):580-587. doi:10.7861/clinmed.2020-0754

Wigley FM, Flavahan NA. Raynaud’s Phenomenon. Campion EW, ed. New England Journal of Medicine. 2016;(6):556-565. doi:10.1056/nejmra1507638

Maltez N, Maxwell LJ, Rirash F, et al. Phosphodiesterase 5 inhibitors (PDE5i) for the treatment of Raynaud’s phenomenon. Cochrane Database of Systematic Reviews. 2023;(11). doi:10.1002/14651858.cd014089

Hotkar MS, Avachat AM, Bhosale SS, Oswal YM. Preliminary investigation of topical nitroglycerin formulations containing natural wound healing agent in diabetes‐induced foot ulcer. International Wound Journal. 2013;(2):210-217. doi:10.1111/iwj.12084

Qiu O, Chan T, Luen M, Cruz JE, Hermes-DeSantis ER. Use of nitroglycerin ointment to treat primary and secondary Raynaud’s phenomenon: a systematic literature review. Rheumatology International. 2018;(12):2209-2216. doi:10.1007/s00296-018-4119-9

Pintea Bentea G, Wauters A, Wautrecht J-C, Cogan E. Laser Doppler imaging evaluation of nitroglycerin patch application in systemic sclerosis patients. Vascular Medicine. 2020;(6):559-568. doi:10.1177/1358863x2095390

Dziadzio M, Denton CP, Smith R, et al. Losartan therapy for Raynaud’s phenomenon and scleroderma: Clinical and biochemical findings in a fifteen-week, randomized, parallel-group, controlled trial. Arthritis & Rheumatism. 1999;(12):2646-2655. doi:10.1002/1529-0131(199912)42:12<2646::aid-anr21>3.0.co;2-t

Górska K, Szczerkowska-Dobosz A, Purzycka-Bohdan D, Stawczyk-Macieja M, Wierzba K, Nowicki RJ. Raynaud’s phenomenon as an interdisciplinary problem. Dermatology Review. Published online 2017:499-508. doi:10.5114/dr.2017.71215

Harding SE, Tingey PC, Pope J, et al. Prazosin for Raynaud’s phenomenon in progressive systemic sclerosis. Cochrane Database of Systematic Reviews. Published online April 27, 1998. doi:10.1002/14651858.cd000956 (Accessed May 14, 2024)

Wollersheim H, Thien T, Fennis J, Van Eiteren P, Laar AV. Double-blind, placebo-controlled study of prazosin in Raynaud’s phenomenon. Clinical Pharmacology and Therapeutics. 1986;(2):219-225. doi:10.1038/clpt.1986.166

Bello RJ, Cooney CM, Melamed E, et al. The Therapeutic Efficacy of Botulinum Toxin in Treating Scleroderma‐Associated Raynaud’s Phenomenon: A Randomized, Double‐Blind, Placebo‐Controlled Clinical Trial. Arthritis & Rheumatology. 2017;(8):1661-1669. doi:10.1002/art.40123

Pace CS, Merritt WH. Extended Periarterial Sympathectomy: Evaluation of Long-term Outcomes. HAND. 2017;(4):395-402. doi:10.1177/1558944717715119

Digital Periarterial Sympathectomy for Severe Ischemia of Raynaud’s Syndrome. Vascular Disease Management. Published January 2007. https://www.hmpgloballearningnetwork.com/site/vdm/content/digital-periarterial-sympathectomy-severe-ischemia-raynaudaos-syndrome (Accessed May 14, 2024)

Cina C, Cina M, Clase C. Endoscopic thoracic sympathectomy for hyperhidrosis: Technique and results. Journal of Minimal Access Surgery. 2007;(4):132. doi:10.4103/0972-9941.38907

Vannucci F, Araújo JA. Thoracic sympathectomy for hyperhidrosis: from surgical indications to clinical results. Journal of Thoracic Disease. 2017;(S3):S178-S192. doi:10.21037/jtd.2017.04.04

van Roon AM, Kuijpers M, van de Zande SC, et al. Treatment of resistant Raynaud’s phenomenon with single-port thoracoscopic sympathectomy: a novel minimally invasive endoscopic technique. Rheumatology. 2019;(5):1021-1025. doi:10.1093/rheumatology/kez386

Thune TH, Ladegaard L, Licht PB. Thoracoscopic Sympathectomy for Raynaud’s Phenomenon—A Long Term Follow-up Study. European Journal of Vascular and Endovascular Surgery. 2006;(2):198-202. doi:10.1016/j.ejvs.2006.01.017

Cameron A. Letter to the Editor re: Thorascopic Sympathectomy or Raynaud’s Phenomenon – A Long Term Follow-up Study. Thune TH, Ladegard L & Licht PB. Eur J Vasc Endovasc Surg 32, 198–202 (2006). European Journal of Vascular and Endovascular Surgery. 2007;(1):133. doi:10.1016/j.ejvs.2006.09.020

Downloads

  • PDF

Published

2024-05-30

How to Cite

1.
MARCZYK, Aleksandra, MAKOWSKA, Karolina, BILLEWICZ, Marta, LIS, Laura, TUREK, Aleksandra, POPIOŁEK, Adam, PIETRZYKOWSKA, Julia and ZATORSKA, Oksana. Review of Raynaud’s phenomenon: pathomechanisms, diagnosis and treatment. Journal of Education, Health and Sport. Online. 30 May 2024. Vol. 72, p. 51508. [Accessed 14 May 2025]. DOI 10.12775/JEHS.2024.72.51508.
  • ISO 690
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
Download Citation
  • Endnote/Zotero/Mendeley (RIS)
  • BibTeX

Issue

Vol. 72 (2024)

Section

Health Sciences

License

Copyright (c) 2024 Aleksandra Marczyk, Karolina Makowska, Marta Billewicz, Laura Lis, Aleksandra Turek, Adam Popiołek, Julia Pietrzykowska, Oksana Zatorska

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0

Stats

Number of views and downloads: 630
Number of citations: 0

Search

Search

Browse

  • Browse Author Index
  • Issue archive

User

User

Current Issue

  • Atom logo
  • RSS2 logo
  • RSS1 logo

Information

  • For Readers
  • For Authors
  • For Librarians

Newsletter

Subscribe Unsubscribe

Tags

Search using one of provided tags:

Raynaud’s phenomenon, Raynauld’s disease, Raynauld’s syndrome, diagnosis, treatment
Up

Akademicka Platforma Czasopism

Najlepsze czasopisma naukowe i akademickie w jednym miejscu

apcz.umk.pl

Partners

  • Akademia Ignatianum w Krakowie
  • Akademickie Towarzystwo Andragogiczne
  • Fundacja Copernicus na rzecz Rozwoju Badań Naukowych
  • Instytut Historii im. Tadeusza Manteuffla Polskiej Akademii Nauk
  • Instytut Kultur Śródziemnomorskich i Orientalnych PAN
  • Instytut Tomistyczny
  • Karmelitański Instytut Duchowości w Krakowie
  • Ministerstwo Kultury i Dziedzictwa Narodowego
  • Państwowa Akademia Nauk Stosowanych w Krośnie
  • Państwowa Akademia Nauk Stosowanych we Włocławku
  • Państwowa Wyższa Szkoła Zawodowa im. Stanisława Pigonia w Krośnie
  • Polska Fundacja Przemysłu Kosmicznego
  • Polskie Towarzystwo Ekonomiczne
  • Polskie Towarzystwo Ludoznawcze
  • Towarzystwo Miłośników Torunia
  • Towarzystwo Naukowe w Toruniu
  • Uniwersytet im. Adama Mickiewicza w Poznaniu
  • Uniwersytet Komisji Edukacji Narodowej w Krakowie
  • Uniwersytet Mikołaja Kopernika
  • Uniwersytet w Białymstoku
  • Uniwersytet Warszawski
  • Wojewódzka Biblioteka Publiczna - Książnica Kopernikańska
  • Wyższe Seminarium Duchowne w Pelplinie / Wydawnictwo Diecezjalne „Bernardinum" w Pelplinie

© 2021- Nicolaus Copernicus University Accessibility statement Shop